article thumbnail

Rising Demand for Pharmaceutical Secondary Packaging Providers

Roots Analysis

This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary packaging and Secondary Packaging solutions. . 3] Some of the advantages offered by pharmaceutical secondary packaging have been depicted below. Company Competitiveness Analysis.

article thumbnail

STAT+: Pharmalittle: Italy probes Pfizer over profit transfers; FDA postpones meeting for OTC birth control pill

STAT

This calls for celebration with a cup of stimulation, and we are opening a new package of Pumpkin Spice for the occasion. The investigation began in February and covers 2017, 2018, and 2019. Autumn, after all, is in full swing. Meanwhile, our ever-growing to-do list requires attention. Sound familiar?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can holograms help in the frontline fight against pharmaceutical counterfeiting?

European Pharmaceutical Review

One area in which the problem can be tackled effectively is product packaging. With predictions that the global market for anticounterfeiting packaging is set to reach almost $250 billion by 2026, growth in authentication and anti-tamper devices such as holograms appear to have a healthy future.” percent to as low as 0.20

Packaging 111
article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake.

article thumbnail

Care … Amazon’s Revolutionary Move into Healthcare

Fuld

In just three years, Amazon has put together a package of leading-edge services that have the potential to revolutionize the US healthcare market. 2018 — Haven, PillPack, and Aiva. Amazon’s public charge into the US healthcare market started in 2018. including Phoenix, Louisville, Detroit, and San Bernardino.

article thumbnail

Injectable opportunities for CMOs despite internal capacity of big pharma sponsors

Pharmaceutical Technology

Large (market cap $10–100bn) and mega-cap (market cap >$100bn) sponsors also require contract manufacturers and packagers with specialist injectable capabilities in the case of cell and gene therapies, as shown in the report titled Contract Injectable Packaging Trends in the Bio/Pharma Industry (August 2022).

article thumbnail

Merck makes circular RNA play with $3.5bn Orna alliance

pharmaphorum

billion, consummating a relationship that first started in 2018 and spanned a range of mRNA-based vaccines for infectious diseases. The oRNAs can also be packaged into lipid nanoparticles, which can help with delivery and potentially can allow them to be targeted to specific tissues in the body.